When brands and consumers expect packaging and labels to do more than their basic functions of communicating information and protecting a product, it raises the stakes for package printers and converters. According to Catherine Haynes, a member of All Printing Resources’ Technical Solutions Group, a flexographic product and service provider, expectations for packaging have never been higher, as the industry strives to turn complex art into vivid, colorful packages — typically on a tight deadline. “We see in all print segments a growing interest to create these user experiences and personalize the packaging message,” Haynes says. “It’s really increasing both quality and overall visual appeal for whatever kind of packaging or labels they’re trying to create. It has pushed our whole industry to up the ante on not only being able to deliver higher quality and more color, but also [work through] the challenges of doing it faster while trying to remain competitive.” Click read more below for additional detail.
SCA has entered into an agreement to acquire BSN medical, a leading medical solutions company, from the private equity group EQT. BSN medical develops, manufactures, markets and sells products within wound care, compression therapy and orthopedics. The purchase price amounts to EUR 2,740m* on a debt- and cash-free basis. The completion of the transaction is subject to customary regulatory approvals. Closing is expected to take place during the second quarter 2017.
BSN medical is an innovative medical solutions company with well-known brands such as Leukoplast, Cutimed, JOBST, Delta Cast, Delta Lite and Actimove which are long established brand leaders in their key markets. BSN medical has a strong go-to-market and supply chain with sales in more than 140 countries and production in 11 countries. BSN medical has approximately 6,000 employees.
“The BSN medical acquisition is an excellent strategic fit for SCA supporting our vision to improve well-being through leading hygiene and health solutions, two closely interlinked areas. BSN medical has leading market positions in several attractive medical product categories and provides a new growth platform with future industry consolidation opportunities. Our incontinence business, with the global leading TENA brand, shares similar positive market characteristics, customer and sales channels, which provide opportunities for accelerated growth through cross-selling,” says Magnus Groth, President and CEO, SCA.
BSN medical reported net sales for year 2015 amounted to EUR 861m (SEK 8,050m) and adjusted EBITDA** of EUR 201m (SEK 1,879m), adjusted operating profit*** of EUR 137m (SEK 1,281m), an adjusted operating margin*** of 15.9% and adjusted return on capital employed*** of 7.7%. The reported net sales for BSN medical for the first nine months of 2016 amounted to EUR 627m (SEK 5,872m), adjusted EBITDA** of EUR 151m (SEK 1,414m), adjusted operating profit*** of EUR 103m (SEK 965m) and an adjusted operating margin*** of 16.4%.
more at: http://www.sca.com/en/Media/Press-releases/Press-releases/2016/SCA-to-acquire-BSN-medical-a-leading-medical-solutions-company-for-EUR-2740m-on-a-debt–and-cash-free-basis/